The Blood Disorders Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center features eight world-class treatment programs offering patients deep expertise and advanced therapies for specific conditions. Each program features an authority in his/her area of expertise as well as teams of subspecialists and nurses with focused training and years of proven experience.
The Bone Marrow Failure Program is recognized as one of the nation’s best pediatric treatment and research programs for bone marrow failure and related conditions.
Our patients have access to advanced treatments and diagnosis, including stem cell transplantation, DNA mutation identification through a certified laboratory, and ongoing clinical trials that are investigating new treatments
The Boston Hemophilia Center is the largest hemophilia treatment center in New England.
This federally funded center provides comprehensive medical evaluation and treatment, ongoing medical management, counseling and support, and access to new treatment approaches through clinical research.
The Myelodysplastic Syndromes Specialty Program has the expertise to diagnose and treat all subtypes of myelodysplastic syndromes (MDS), including low grade and high-grade forms of the disease.
We are one of the most experienced programs in the world at treating children with MDS, offering specialized diagnostic and treatment options that include stem cell transplant.
The Platelet Function Disorders Program provides comprehensive care for children and adolescents with platelet function disorders as well as access to the most recent clinical trials.
Under the direction of Alan Michelson, MD, the program is the leading authority on platelet disorder treatment and research.
Dana-Farber/Boston Children's Ellis Neufeld, MD talks about giving children with serious blood disorders a chance for a normal life.